$7.49
2.47%
Nasdaq, Jul 18, 10:00 pm CET
ISIN
US5147661046
Symbol
LFCR

Landec Corporation Stock price

$7.49
+0.78 11.62% 1M
+1.01 15.59% 6M
+0.06 0.81% YTD
+2.40 47.15% 1Y
-2.29 23.42% 3Y
-1.65 18.05% 5Y
-6.57 46.73% 10Y
+1.36 22.19% 20Y
Nasdaq, Closing price Fri, Jul 18 2025
-0.19 2.47%
ISIN
US5147661046
Symbol
LFCR

Key metrics

Basic
Market capitalization
$277.3m
Enterprise Value
$396.8m
Net debt
$119.5m
Cash
$5.4m
Shares outstanding
37.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.1 | 2.1
EV/Sales
3.1 | 3.0
EV/FCF
negative
P/B
5.9
Financial Health
Equity Ratio
21.2%
Return on Equity
22.3%
ROCE
-4.1%
ROIC
-3.8%
Debt/Equity
2.6
Financials (TTM | estimate)
Revenue
$130.3m | $130.4m
EBITDA
$-100.0k | $19.8m
EBIT
$-8.5m | $-4.0m
Net Income
$-49.4m | $-50.2m
Free Cash Flow
$-10.9m
Growth (TTM | estimate)
Revenue
12.4% | 1.6%
EBITDA
95.5% | 1,083.8%
EBIT
27.9% | 44.6%
Net Income
-199.8% | -518.2%
Free Cash Flow
67.6%
Margin (TTM | estimate)
Gross
33.5%
EBITDA
-0.1% | 15.2%
EBIT
-6.5%
Net
-37.9% | -38.5%
Free Cash Flow
-8.3%
More
EPS
$-1.3
FCF per Share
$-0.3
Short interest
10.9%
Employees
524
Rev per Employee
$240.0k
Show more

Is Landec Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Landec Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Landec Corporation forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Landec Corporation forecast:

Buy
78%
Hold
22%

Financial data from Landec Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
130 130
12% 12%
100%
- Direct Costs 87 87
5% 5%
67%
44 44
32% 32%
33%
- Selling and Administrative Expenses 44 44
21% 21%
34%
- Research and Development Expense 8.32 8.32
8% 8%
6%
-0.10 -0.10
96% 96%
0%
- Depreciation and Amortization 8.37 8.37
12% 12%
6%
EBIT (Operating Income) EBIT -8.46 -8.46
28% 28%
-6%
Net Profit -49 -49
200% 200%
-38%

In millions USD.

Don't miss a Thing! We will send you all news about Landec Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Landec Corporation Stock News

Neutral
GlobeNewsWire
3 days ago
CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, 2025, the Lifecore compensation committee approved grants under Lifecore's Equity Inducement Plan, as amended (the “Inducement Plan”) of restricted stock unit (“RSU”) awards with r...
Neutral
Seeking Alpha
12 days ago
June saw a record number of 48 new Seeking Alpha analysts, each bringing fresh stock ideas and unique backgrounds to the platform. Analysts provided ratings from Sell to Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bullish views on Alphabet, TSM, AppLovin, and Rolls-Royce, a bearish call Samsara, an...
Positive
Seeking Alpha
about one month ago
Lifecore Biomedical is emerging from a challenging restructuring and is now a pure play CDMO with new management, an improved balance sheet, expanded capacity, and a solid business plan. Industry dynamics and recent M&A suggest a decent chance of a near-term acquisition, potentially valuing LFCR at 2x its current price. LFCR's growth runway and customer stickiness support its premium valuation,...
More Landec Corporation News

Company Profile

Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Curation Foods, Lifecore, and Others. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Clara, CA.

Head office United States
CEO Paul Josephs
Employees 524
Founded 1986
Website www.lifecore.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today